Loading patent…
AssigneeTapimmune, Inc.
InventorsWilfred Arthur Jefferies, Timothy Z. Vitalis, Quian-Jin Zhang, Judi Barbara Alimonti, Susan Shu-Ping Chen, Genc Basha, Kyung Bok Choi
Estimating the term…
A vaccine composition for combating Pox viridae viral infections in living organisms such as mammals (including humans) comprises TAP-1 and/or TAP-2 to augment the antigen processing capability of infected cells and hence their immunogenicity. The composition may be used alone or, preferably, as an immunogenicity-enhancing adjuvant with a pox antigen-based vaccine, especially in the treatment or prophylaxis of viral infections such as smallpox.
A pharmaceutical composition for administration to a living organism for the treatment or prophylaxis of Pox viridae infections, the composition consisting essentially of
2-5. (canceled)
(canceled)
10-14. (canceled)
17-18. (canceled)
Dependencies are inferred from the claim text.